Department of Molecular Pharmacology, Physiology and Biotechnology

Chair

Guided by a mission to apply insight gained from scientific inquiry to advance the treatment of illness and injury, faculty research interests within the Department of Molecular Pharmacology, Physiology and Biotechnology (MPPB) are diverse and include molecular and structural pharmacology; the molecular and cellular basis for drug addiction; cellular and intracellular signaling in cancer and neurodegeneration; macromolecular structure; cellular, comparative, and organ systems physiology; biomaterials; organ replacement, tissue engineering, gene therapy, and regenerative medicine. Research objectives are translated into innovation by faculty with extensive experience in the biotechnology and biomedical device industry.

The Department's fourteen faculty members support graduate, medical, and postdoctoral education within an interdisciplinary framework of training programs in classical theory and newly emerging areas of biomedical sciences. Doctoral degree programs are offered in three programmatic tracks.

View Molecular Pharmacology, Physiology and Biotechnology site

• Administrative Departments
• Centers, Institutes, Programs